Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114632318> ?p ?o ?g. }
- W2114632318 endingPage "513" @default.
- W2114632318 startingPage "508" @default.
- W2114632318 abstract "The coexistence of potentially aggravating processes is common in asthmatics, particularly in patients with difficult control. The primary aim of this study is to ascertain whether comorbidity is more common in uncontrolled patients. As a secondary aim, we propose to evaluate the correlation between the asthma control test (ACT) and the fraction of exhaled nitric oxide (FENO). A prospective, observational study comparing the function and clinical picture of two groups of asthmatics: controlled (ACT≥20) and uncontrolled (ACT<20). They were all assessed for, smoking, rhinosinusitis, obesity, anxiety, depression, vocal chord dysfunction, gastro-oesophageal reflux (GORD), allergic bronchopulmonary aspergillosis (ABPA), COPD and nasal polyps. A total of 50 patients with controlled asthma and 102 with sub-optimal control were included. The patients with an ACT≥20 had better lung function, less variation in PEF, less bronchial hyper-reactivity and lower FENO values. Comorbidities were found in 95% of the controlled asthmatics and in 97% of the uncontrolled. Only the presence of nasal polyps, GORD and ABPA was more frequent in the uncontrolled group. However, the simultaneous presence of 3 or more comorbidity factors was significantly more frequent in patients with sub-optimal control (P=.01). There was no significant correlation between the FENO and the ACT values (rho=−0.08; P=.32). Aggravating comorbidities are more common in patients with sub-optimal control. There was no correlation between the FENO and the ACT values. La coexistencia de procesos potencialmente agravantes es frecuente en asmáticos, especialmente en individuos con control difícil. Es objetivo primario conocer si la comorbilidad es más frecuente en los pacientes no controlados. Como objetivo secundario nos propusimos evaluar el grado de correlación entre test de control del asma (ACT) y la fracción exhalada de óxido nítrico (FENO). Estudio prospectivo, observacional, que comparó funcional y clínicamente dos grupos de asmáticos: controlados (ACT ≥ 20) y no controlados (ACT < 20). En todos se investigó la presencia de tabaquismo, rinosinusitis, obesidad, ansiedad, depresión, disfunción de cuerdas vocales, reflujo gastroesofágico (RGE), aspergilosis broncopulmonar alérgica (ABPA), EPOC y poliposis nasal. Se incluyeron 56 pacientes con asma controlada y 102 con un control subóptimo. Lós pacientes con un ACT ≥ 20 tenían mejor función pulmonar, menor variabilidad del PEF, menos hiperreactividad bronquial y menores valores de FENO. Se hallaron comorbilidades en el 95% de los asmáticos controlados y en el 97% de los no controlados. Sólo la presencia de poliposis nasal, RGE y ABPA fue más frecuente en el grupo no controlado. Sin embargo, la presencia simultánea de 3 o más factores de comorbilidad fue significativamente más frecuente en los pacientes con un control subóptimo (P = 0,01). No hubo correlación significativa entre los valores del FENO y los del ACT (rho = −0,08; P = 0,32). La suma de comorbilidades agravantes es más frecuente en pacientes con control subóptimo. No existe correlación entre los valores de ACT y de FENO." @default.
- W2114632318 created "2016-06-24" @default.
- W2114632318 creator A5002192177 @default.
- W2114632318 creator A5018057721 @default.
- W2114632318 creator A5020875283 @default.
- W2114632318 creator A5065856570 @default.
- W2114632318 creator A5067984302 @default.
- W2114632318 creator A5074347811 @default.
- W2114632318 date "2010-10-01" @default.
- W2114632318 modified "2023-10-17" @default.
- W2114632318 title "Relationship Between Comorbidity and Asthma Control" @default.
- W2114632318 cites W1953300272 @default.
- W2114632318 cites W1965863574 @default.
- W2114632318 cites W1981015531 @default.
- W2114632318 cites W2006283019 @default.
- W2114632318 cites W2014317758 @default.
- W2114632318 cites W2017104788 @default.
- W2114632318 cites W2054699999 @default.
- W2114632318 cites W2073647973 @default.
- W2114632318 cites W2081644697 @default.
- W2114632318 cites W2091722094 @default.
- W2114632318 cites W2095864630 @default.
- W2114632318 cites W2105524119 @default.
- W2114632318 cites W2112693061 @default.
- W2114632318 cites W2125078269 @default.
- W2114632318 cites W2128838509 @default.
- W2114632318 cites W2134468004 @default.
- W2114632318 cites W2137401824 @default.
- W2114632318 cites W2142069498 @default.
- W2114632318 cites W2142761132 @default.
- W2114632318 cites W2145977358 @default.
- W2114632318 cites W2148583736 @default.
- W2114632318 cites W2157369643 @default.
- W2114632318 cites W2159371369 @default.
- W2114632318 cites W2165829211 @default.
- W2114632318 cites W2166258038 @default.
- W2114632318 cites W2167384684 @default.
- W2114632318 cites W2184017757 @default.
- W2114632318 cites W2616424562 @default.
- W2114632318 doi "https://doi.org/10.1016/s1579-2129(11)60003-7" @default.
- W2114632318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20638762" @default.
- W2114632318 hasPublicationYear "2010" @default.
- W2114632318 type Work @default.
- W2114632318 sameAs 2114632318 @default.
- W2114632318 citedByCount "12" @default.
- W2114632318 countsByYear W21146323182012 @default.
- W2114632318 countsByYear W21146323182013 @default.
- W2114632318 countsByYear W21146323182015 @default.
- W2114632318 countsByYear W21146323182018 @default.
- W2114632318 countsByYear W21146323182019 @default.
- W2114632318 countsByYear W21146323182020 @default.
- W2114632318 countsByYear W21146323182021 @default.
- W2114632318 countsByYear W21146323182022 @default.
- W2114632318 crossrefType "journal-article" @default.
- W2114632318 hasAuthorship W2114632318A5002192177 @default.
- W2114632318 hasAuthorship W2114632318A5018057721 @default.
- W2114632318 hasAuthorship W2114632318A5020875283 @default.
- W2114632318 hasAuthorship W2114632318A5065856570 @default.
- W2114632318 hasAuthorship W2114632318A5067984302 @default.
- W2114632318 hasAuthorship W2114632318A5074347811 @default.
- W2114632318 hasConcept C126322002 @default.
- W2114632318 hasConcept C141071460 @default.
- W2114632318 hasConcept C23131810 @default.
- W2114632318 hasConcept C2776042228 @default.
- W2114632318 hasConcept C2777014526 @default.
- W2114632318 hasConcept C2777768476 @default.
- W2114632318 hasConcept C2779134260 @default.
- W2114632318 hasConcept C2779159551 @default.
- W2114632318 hasConcept C2780333948 @default.
- W2114632318 hasConcept C2781142857 @default.
- W2114632318 hasConcept C2781390199 @default.
- W2114632318 hasConcept C43270747 @default.
- W2114632318 hasConcept C71924100 @default.
- W2114632318 hasConcept C75603125 @default.
- W2114632318 hasConcept C90924648 @default.
- W2114632318 hasConceptScore W2114632318C126322002 @default.
- W2114632318 hasConceptScore W2114632318C141071460 @default.
- W2114632318 hasConceptScore W2114632318C23131810 @default.
- W2114632318 hasConceptScore W2114632318C2776042228 @default.
- W2114632318 hasConceptScore W2114632318C2777014526 @default.
- W2114632318 hasConceptScore W2114632318C2777768476 @default.
- W2114632318 hasConceptScore W2114632318C2779134260 @default.
- W2114632318 hasConceptScore W2114632318C2779159551 @default.
- W2114632318 hasConceptScore W2114632318C2780333948 @default.
- W2114632318 hasConceptScore W2114632318C2781142857 @default.
- W2114632318 hasConceptScore W2114632318C2781390199 @default.
- W2114632318 hasConceptScore W2114632318C43270747 @default.
- W2114632318 hasConceptScore W2114632318C71924100 @default.
- W2114632318 hasConceptScore W2114632318C75603125 @default.
- W2114632318 hasConceptScore W2114632318C90924648 @default.
- W2114632318 hasIssue "10" @default.
- W2114632318 hasLocation W21146323181 @default.
- W2114632318 hasLocation W21146323182 @default.
- W2114632318 hasOpenAccess W2114632318 @default.
- W2114632318 hasPrimaryLocation W21146323181 @default.
- W2114632318 hasRelatedWork W1945679044 @default.
- W2114632318 hasRelatedWork W1980491720 @default.
- W2114632318 hasRelatedWork W2145180660 @default.